Singapore: US-based Colorcon, a world leader in offering development, supply and technical support to the pharmaceutical industry has opened a new technical service laboratory in Beijing, China.

Located in the Beijing YiZhuang Biomedical Park, this technical centre is in a unique position to work closely with the pharmaceutical research community in the North China region on developing immediate and modified release solid oral dose formulations.

The laboratory will provide specialist support to accelerate development and commercialization of robust, high quality pharmaceutical drug formulations.

Mr Simon Tasker, MD, Colorcon NESEA, commented, "Investment in the Beijing facility reflects our view of the strategic significance of Northern China from a long‐term growth perspective. It reinforces our commitment to providing best‐in‐class products and services through a network of laboratories positioned close to our customers."

Mr Martti Hedman, CEO, Colorcon explained, "Since establishing Shanghai Colorcon Coating Technology Limited in 1993, Colorcon has continued to make strategic investments in China."